TAUNS Laboratories,Inc.

197A・Standard Market・Pharmaceuticals

Official website

TAUNS Laboratories,Inc.

197A・Standard Market・Pharmaceuticals

Official website

TAUNS Laboratories,Inc.197A

Reference Indicators

Market Cap

512¥100M

P/E (Forecast)

8.8x

P/B

2.8x

Dividend Yield (Forecast)

—

ROE

40.7%

EV/EBITDA

6.3x

Financial Summary

Unit: ¥M

Item	2024Jun 2024	2025Jun 2025
Net Sales	18,434	18,627
Cost of Sales	5,936	5,852
Gross Profit	12,498	12,774
SG&A Expenses	4,468	4,509
Operating Income	8,030	8,265
Non-operating Income	63	60
Non-operating Expenses	253	105
Ordinary Income	7,840	8,219
Extraordinary Income	2	3
Extraordinary Losses	8	21
Pre-tax Income	7,834	8,201
Income Taxes	2,060	1,886
Net Income	5,774	6,315
EBITDA	8,706	8,980
Gross Margin	67.8%	68.6%
Operating Margin	43.6%	44.4%
ROA	19.7%	17.3%
ROE	52.2%	40.7%